Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Suhler

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Ophthalmology|January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive FactorsJohn H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 23, 2016
Adalimumab for Ocular InflammationKhayyam Durrani, John H Kempen, Gui-Shuang Ying, et al.
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Ophthalmology|December 22, 2015
Risk of Retinal Neovascularization in Cases of UveitisApurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
American Journal of Ophthalmology|July 5, 2020
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive FactorsDeepika N Shah, Ahmad Al-Moujahed, Craig W Newcomb, et al.
Journal of Ophthalmic Inflammation and Infection|June 9, 2023
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trialAmit K Reddy, D Claire Miller, Amol A Sura, et al.
Ophthalmology|March 6, 2021
Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for UveitisNicole K Kelly, Aheli Chattopadhyay, S R Rathinam, et al.
Ophthalmology|April 24, 2017
Risk of Ocular Hypertension in Adults with Noninfectious UveitisEbenezer Daniel, Maxwell Pistilli, Srishti Kothari, et al.
American Journal of Ophthalmology|April 6, 2019
Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive FactorsJohn H Kempen, Maxwell Pistilli, Hosne Begum, et al.
The Journal of Rheumatology|July 3, 2013
Response of pediatric uveitis to tumor necrosis factor-α inhibitorsMelissa A Lerman, Jon M Burnham, Peter Y Chang, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Ophthalmology|January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive FactorsJohn H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 23, 2016
Adalimumab for Ocular InflammationKhayyam Durrani, John H Kempen, Gui-Shuang Ying, et al.
The New England Journal of Medicine|September 8, 2016
Adalimumab in Patients with Active Noninfectious UveitisGlenn J Jaffe, Andrew D Dick, Antoine P Brézin, et al.
Ophthalmology|December 22, 2015
Risk of Retinal Neovascularization in Cases of UveitisApurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
American Journal of Ophthalmology|July 5, 2020
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive FactorsDeepika N Shah, Ahmad Al-Moujahed, Craig W Newcomb, et al.
Journal of Ophthalmic Inflammation and Infection|June 9, 2023
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trialAmit K Reddy, D Claire Miller, Amol A Sura, et al.
Ophthalmology|March 6, 2021
Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for UveitisNicole K Kelly, Aheli Chattopadhyay, S R Rathinam, et al.
Ophthalmology|April 24, 2017
Risk of Ocular Hypertension in Adults with Noninfectious UveitisEbenezer Daniel, Maxwell Pistilli, Srishti Kothari, et al.
American Journal of Ophthalmology|April 6, 2019
Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive FactorsJohn H Kempen, Maxwell Pistilli, Hosne Begum, et al.
The Journal of Rheumatology|July 3, 2013
Response of pediatric uveitis to tumor necrosis factor-α inhibitorsMelissa A Lerman, Jon M Burnham, Peter Y Chang, et al.
Pageof 14